Fluorescence Spectroscopy for Gut Permeability Assessment
NCT03434639 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2020-02-12
Summary
This research aims to develop portable devices - known as fluorescence spectrometers - to monitor the leakage of fluorescent dyes out of the gut into the blood stream. These devices will measure the leakiness (permeability) of the gut in a non-invasive manner and will provide an early warning that patients are at risk of infections caused by the unwanted flow of bacteria from the intestine to the rest of the body.
Conditions
- Development and Validation of Gut Permeability Sensor
- Permeability; Increased
- Celiac Disease
- Inflammatory Bowel Diseases
- Liver Diseases
- HIV/AIDS
Interventions
- DIAGNOSTIC_TEST
-
Spectroscopic gut permeability test
The spectroscopic gut permeability test first involves patients receiving an oral dose of one or more fluorescent dyes. A wearable sensor will then be attached to the patients' skin and this will be used to monitor the leakage of the fluorescent dyes from the intestine into the blood stream in a non-invasive manner. In this way, a measure of the permeability of the intestine will be obtained. Note that patients in Group 1 (ophthalmology patients) will not receive oral doses of contrast agents. Instead, the wearable sensor will simply be used to detect the presence of fluorescent dyes that were administered intravenously as part of planned ophthalmic procedures. Complete details of the spectroscopic gut permeability test can be found in the attached protocol.
Sponsors & Collaborators
-
Imperial College London
lead OTHER
Principal Investigators
-
Alex J Thompson, PhD · Imperial College London
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-03-29
- Primary Completion
- 2021-09-30
- Completion
- 2021-09-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Effect of UGIR in Adults With Compromised Gut Function and Malabsorption
NCT03011593 ·Status: COMPLETED ·Phase: NA
-
Quantification of Gluten Peptides in Feces
NCT02711397 ·Status: COMPLETED
-
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
NCT03409796 ·Status: COMPLETED ·Phase: NA
-
Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease
NCT03462979 ·Status: SUSPENDED ·Phase: NA
-
Gluten-free Diet Monitoring in Urine
NCT02344758 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Can a Very High Result From a Screening Test for Celiac Disease be Used to Diagnose Celiac Disease?
NCT00175760 ·Status: COMPLETED
-
Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease
NCT06324539 ·Status: RECRUITING
-
Gluten Sensor Device to Promote Gluten Free Diet Adherence and Quality of Life in Patients With Celiac Disease
NCT03321214 ·Status: COMPLETED ·Phase: NA
-
Assessment of Coeliac Disease in Patients With Type 2 Diabetes
NCT06283264 ·Status: NOT_YET_RECRUITING
-
Celiac Disease Screening
NCT01902368 ·Status: TERMINATED ·Phase: NA
-
Intestinal Transglutaminase Antibodies in Celiac Disease Diagnosis
NCT05810441 ·Status: COMPLETED
-
Detection of Immunotoxic Gluten Peptides in Feces
NCT01478867 ·Status: COMPLETED
-
Case Finding for Coeliac Disease Using a Point of Care Test in a Pharmacy Setting
NCT02675283 ·Status: COMPLETED ·Phase: NA
-
Gluten-free Diet in Gluten-genetically Predisposed Subjects
NCT00677495 ·Status: COMPLETED ·Phase: NA
-
Changes in Intestinal Permeability 4 Hours After Gluten Challenge
NCT03288831 ·Status: COMPLETED ·Phase: NA
-
Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay.
NCT02242123 ·Status: COMPLETED
-
Evaluate the Use of Optical Frequency Domain Imaging (OFDI) for Celiac Disease in Children, Adolescents and Young Adults
NCT01439035 ·Status: COMPLETED ·Phase: NA
-
Performance Evaluation of Capsule Endoscopy in the Diagnosis of Gluten Sensitive Enteropathy (MA-23)
NCT00555737 ·Status: COMPLETED
-
Intestinal Permeability, Nutritional Status and Quality of Life in Celiac Disease
NCT04351828 ·Status: COMPLETED
-
Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients
NCT02389062 ·Status: COMPLETED ·Phase: NA
-
Immunologic Basis of Food Protein-Induced Enterocolitis Syndrome
NCT06683521 ·Status: RECRUITING ·Phase: NA
-
Enteroscopy for Early Diagnosis of Tumors in Celiac Disease
NCT02325232 ·Status: UNKNOWN ·Phase: NA
-
Serum Markers in Gluten Challenge
NCT00931892 ·Status: COMPLETED ·Phase: NA
-
Assessment of Adherence to Gluten Free Diet in Children and Adolescents by Detection of Gluten in Faecal Samples.
NCT03663309 ·Status: COMPLETED
-
Gluten Ingestion Biomarkers in Patients w Gluten Sensitivity and Healthy Controls Peptides in Patients With Non-celiac Gluten Sensitivity and Healthy Patients: A Placebo-controlled Study
NCT02936297 ·Status: COMPLETED ·Phase: NA